Table 4.
Hip circumference
|
||||
---|---|---|---|---|
1st tertile (<102.0 cm) | 2nd tertile (102.0–110.1 cm) | 3rd tertile (≥110.1 cm) | ||
Waist circumference | 1st tertile (<100.8 cm) | 195/43 | 46/7 | 1/1 |
1 (reference) | 0.690 (0.292 to 1.63) | n/a* | ||
1 (reference) | 1.08 (0.435 to 2.70) | n/a* | ||
2nd tertile (100.8–111.9 cm) | 36/17 | 136/56 | 44/12 | |
2.14 (1.10 to 4.16) | 1.87 (1.19 to 2.94) | 1.24 (0.603 to 2.54) | ||
2.14 (1.01 to 4.50) | 1.70 (1.01 to 2.86) | 1.15 (0.502 to 2.63) | ||
3rd tertile (≥111.9 cm) | 2/0 | 39/19 | 176/70 | |
n/a* | 2.21 (1.17 to 4.19) | 1.80 (1.17 to 2.78) | ||
n/a* | 1.97 (0.929 to 4.16) | 1.54 (0.935 to 2.54) |
The 1st line of each cell is the number of patients without BO or EO/number with BO or EO. The 2nd line of each cell is the crude OR (95% CI). The 3rd line of each cell is the OR (95% CI) adjusted for age, pack-years of cigarette use, daily energy intake, proportion of energy from fat, and physical activity.
The effects could not be validly estimated.